Table 4 Laboratory parameters.

From: Feasibility, classification and potential clinical impact of non-invasive delineation of abdominal lymphatic vessels in patients following TCPC with T2 weighted MRI

 

Group 1 (n = 15)

Group 2 (n = 18)

 

PLE (history and current)

4

1

p = 0.092

Chi2(1) 2.836

Chylothorax (history)

7

2

p = 0.022*

Chi2(1) 5.215

PB (history and current)

3

1

p = 0.206

Chi2(1) 1.603

Liver ultrasound findings:

Heterogenous liver structure (y/n)

8/7

8/10

p = 0.611

Chi2(1) 0.259

Nodular surface (y/n)

7/8

8/10

p = 0.898

Chi2(1) 0.16

Splenomegaly (y/n)

7/6

6/9

p = 0.464

Chi2(1) 0.537

Liver fibrosis (y/n)

7/8

6/12

p = 0.435

Chi2(1) 0.609

Portal hypertension (y/n)

6/7

4/11

p = 0.283

Chi2(1) 1.152

  1. Significant values are in bold.